BCAL Diagnostics (ASX:BDX) Other Stockholders Equity : A$-0.00 Mil (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is BCAL Diagnostics Other Stockholders Equity?

BCAL Diagnostics's Other Stockholders Equity for the quarter that ended in Dec. 2023 was A$-0.00 Mil.

BCAL Diagnostics's quarterly Other Stockholders Equity increased from Dec. 2022 (A$0.00 Mil) to Jun. 2023 (A$0.00 Mil) but then declined from Jun. 2023 (A$0.00 Mil) to Dec. 2023 (A$-0.00 Mil).

BCAL Diagnostics's annual Other Stockholders Equity increased from . 20 (A$0.00 Mil) to Jun. 2022 (A$0.00 Mil) but then declined from Jun. 2022 (A$0.00 Mil) to Jun. 2023 (A$0.00 Mil).

BCAL Diagnostics Other Stockholders Equity Historical Data

The historical data trend for BCAL Diagnostics's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BCAL Diagnostics Other Stockholders Equity Chart

BCAL Diagnostics Annual Data

Trend

Jun22

Jun23

Other Stockholders Equity

BCAL Diagnostics Semi-Annual Data
	Dec20	Dec21	Jun22	Dec22	Jun23	Dec23
Other Stockholders Equity	Get a 7-Day Free Trial			-	-	-	-	-

BCAL Diagnostics Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

BCAL Diagnostics Other Stockholders Equity Related Terms

Thank you for viewing the detailed overview of BCAL Diagnostics's Other Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

BCAL Diagnostics (ASX:BDX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » BCAL Diagnostics Ltd (ASX:BDX) » Definitions » Other Stockholders Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

Queen Victoria Building, GPO Box Q128, Sydney, NSW, AUS, 1230

Website

https://www.bcaldiagnostics.com

BCAL Diagnostics Ltd is a biotechnology company developing a novel blood screening test to improve the early diagnosis and monitoring of breast cancer by identifying, measuring, and validating specific biomarkers enriched from patient's blood. The BCAL technology utilizes a single blood test on multiple levels including disease detection, diagnostic mass screening, and post-intervention.